Insider Trading March 17, 2026

Integer Holdings VP Disposes $70,125 in Stock as Company Posts Q4 Beat and Board Changes

Corporate controller sells 825 shares; Integer reports stronger-than-expected fourth-quarter results and adds two independent directors under activist agreement

By Caleb Monroe ITGR
Integer Holdings VP Disposes $70,125 in Stock as Company Posts Q4 Beat and Board Changes
ITGR

Tommy P. Thomas, vice president and corporate controller of Integer Holdings Corp (NYSE: ITGR), sold 825 shares on March 13, 2026, for $70,125. The company recently reported fourth-quarter 2025 results that topped estimates and announced the appointment of two independent directors as part of a cooperation agreement with activist investor Irenic Capital Management. InvestingPro analysis cited in filings characterizes the stock as undervalued with a "GOOD" financial health score and anticipates net income growth this year.

Key Points

  • Integer VP and corporate controller Tommy P. Thomas sold 825 shares on March 13, 2026, for $85.0 per share, totaling $70,125; he now directly owns 4,381 shares.
  • Integer reported Q4 2025 revenue of $472.1 million, a 5% year-over-year increase, and adjusted EPS of $1.76 - both figures exceeded specified estimates.
  • The company appointed two independent directors, James Flanagan and Aaron Kapito, as part of a cooperation agreement with activist investor Irenic Capital Management; Benchmark upgraded the stock to Buy with a $95 target.

Integer Holdings Corp (NYSE:ITGR) reported an insider sale and a set of financial and governance developments that investors will weigh alongside recent quarterly results. According to a Form 4 filing with the Securities and Exchange Commission, Tommy P. Thomas, vice president and corporate controller, sold 825 shares of Integer common stock on March 13, 2026.

The shares were executed at $85.0 apiece, producing a gross transaction value of $70,125. Following the sale, Thomas directly holds 4,381 shares of Integer. At the time of the filing, the stock was trading at $87.21 and the company carried a market capitalization of $2.98 billion.

The filing also references InvestingPro analysis, which describes the stock as appearing undervalued at current levels and assigns Integer a "GOOD" financial health score. That same analysis indicates net income is expected to grow this year and points readers to a Pro Research Report for more detailed examination of the companys outlook.


Separately, Integer disclosed fourth-quarter results for fiscal 2025 that exceeded several external estimates. Revenue in the quarter reached $472.1 million, a 5% increase compared with the prior year and above Benchmarks estimate of $460 million. The company's adjusted earnings per share were $1.76, beating Wall Street consensus of $1.70 and Benchmarks $1.66 forecast.

In response to the quarter, Benchmark raised its rating on Integer from Hold to Buy and set a price target of $95. The company also announced governance changes, naming James Flanagan and Aaron Kapito as independent directors. Those appointments were made in connection with a cooperation agreement with activist investor Irenic Capital Management.

Taken together, the insider transaction, the quarterly beat, and the board additions represent a cluster of developments that touch valuation commentary, near-term earnings expectations, and corporate governance. The public filings and third-party analysis cited in company disclosures form the basis for these facts; additional interpretation or forward-looking judgments beyond the documents is not provided in the filings.


Context and next steps

The Form 4 filing documents the sale and current holdings of the named officer. The companys quarterly results and Benchmarks subsequent rating change were disclosed in Integers releases, and the two board appointments were noted as part of the cooperation agreement with Irenic Capital Management. Investors seeking deeper analysis can refer to the Pro Research Report referenced in the InvestingPro commentary noted in the filings.

Risks

  • Projections and assessments in the filings include forward-looking expectations such as InvestingPros forecast that net income will grow this year, which remain subject to uncertainty - impacts capital markets and investor decision-making.
  • Governance changes under a cooperation agreement with an activist investor introduce uncertainty about future strategic direction and board dynamics - impacts corporate governance and investor relations.
  • Differences between third-party valuation assessments (InvestingPro calling the stock undervalued) and market pricing create valuation uncertainty for shareholders - impacts equity valuation and trading activity.

More from Insider Trading

Navitas CFO Sells $1.06M of NVTS Stock Amid Transition and Product Announcements Mar 17, 2026 Astera Labs Director Disposes $325,000 in Stock as Company Posts Strong Q4 Results Mar 17, 2026 GeneDx CEO Sells $1.32M in WGS Stock to Meet RSU Tax Withholding Mar 17, 2026 PACS Group COO Sells $1.24M in Shares as Stock Trades Well Above Analyst Targets Mar 17, 2026 GeneDx CFO Disposes $438K in Stock Following Zero-Strike Option Exercise Mar 17, 2026